Presentation highlights include 48-month data from the OAKS and DERBY trials as well as the GALE open-label extension.

The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and ...

KAIST developed a microbial strain for efficient lutein production, offering an eco-friendly alternative to traditional ...

Alcon’s Voyager is a fully automated, noncontact treatment approach that delivers 120 laser pulses through the limbus of the ...

The tool is designed to help with the application of mono-dose, dry eye eyedrop vials more easily and accurately.

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...